Vitamin E DL-Alpha-Tocopherol Encyclopedia — Scientific Background

What Is DL-Alpha-Tocopherol?

DL-Alpha-Tocopherol (CAS 2074-53-5), also known as all-rac-α-tocopherol, synthetic vitamin E, or racemic α-tocopherol, is a fat-soluble antioxidant with the molecular formula C₂₉H₅₀O₂ and a molecular weight of 430.71 g/mol. The compound is chemically designated as (RS)-2,5,7,8-tetramethyl-2-((4RS,8RS)-4,8,12-trimethyltridecyl)chroman-6-ol and consists of eight stereoisomers in equal amounts, forming a racemic mixture. DL-α-Tocopherol occurs as a pale yellow to yellow, clear, viscous oil that is practically insoluble in water, freely soluble in ethanol, and miscible with fats and oils.

Synthetic vs. Natural Vitamin E

Vitamin E is available in both synthetic and natural forms, which differ in their stereochemical configuration and biological activity:

Synthetic Vitamin E (DL-α-Tocopherol, CAS 2074-53-5) — Produced from petrochemical-derived trimethylhydroquinone and isophytol. It is a racemic mixture of eight stereoisomers, of which only one (RRR-) is biologically equivalent to natural vitamin E. Synthetic vitamin E is less expensive but has lower biological activity per milligram compared to the natural form.

Natural-Source Vitamin E (D-α-Tocopherol, CAS 59-02-9) — Produced from natural sources such as soybean oil, sunflower oil, and wheat germ oil. It consists of a single stereoisomer (RRR-α-tocopherol) and is the form that occurs naturally in plants and human tissues. Natural-source vitamin E has higher biological activity and is the preferred form for supplementation.

Synthetic supplements of vitamin E (all rac-alpha-tocopherol labeled as “DL-” or “dl-alpha-tocopherol”) are only half as active as the same amount (by weight in mg) of the natural form of the vitamin (labeled as “D-” or “d-alpha-tocopherol”). The primary role of α-tocopherol in liposomes is to function as a chain-breaking antioxidant. The molar ratio of α-tocopherol in liposomes is typically 1–15 mol% of total lipid, though higher concentrations (up to 33 mol%) are possible but may impact membrane fluidity.

Physiological Functions of Vitamin E

Vitamin E is critical for numerous physiological functions:

• Antioxidant Defense — Vitamin E is the body‘s primary lipid-phase antioxidant, protecting polyunsaturated fatty acids (PUFAs) in cell membranes, low-density lipoproteins (LDL), and other lipid-rich structures from peroxidation. It acts as a chain-breaking antioxidant, interrupting the propagation of lipid peroxidation reactions.

• Cardiovascular Health — Vitamin E protects LDL particles from oxidative modification, a key early step in atherosclerosis. It also supports healthy blood vessel function and helps maintain optimal cholesterol levels.

• Skin Protection — Vitamin E shields the skin from oxidative stress caused by UV radiation and environmental pollutants, supporting skin barrier integrity and reducing signs of photoaging.

• Immune Function — Vitamin E modulates immune function by supporting lymphocyte proliferation and antibody production, and by protecting immune cell membranes from oxidative damage.

• Cellular Longevity — Vitamin E enhances cellular resilience and supports healthy aging through superior biological activity and protection of cellular membranes from oxidative damage.

• Eye Health — Vitamin E helps prevent eye diseases such as cataracts and age-related macular degeneration.

Mechanisms of Action

Chain-Breaking Antioxidant Activity

Vitamin E functions as a chain-breaking antioxidant by donating a hydrogen atom from its chromanol ring to lipid peroxyl radicals, forming a lipid hydroperoxide and a relatively stable vitamin E radical (tocopheroxyl radical). This reaction interrupts the chain propagation of lipid peroxidation, preventing further oxidative damage to polyunsaturated fatty acids in cell membranes and lipoproteins.

Lymphatic Absorption and liposomal Delivery

Conventional vitamin E absorption occurs primarily through bile salt-mediated micelle formation in the small intestine, followed by incorporation into chylomicrons and transport via the lymphatic system. Liposomal encapsulation enhances absorption by providing a pre-formed lipid carrier that bypasses some of these limitations. In a comparative study, α-tocopherol recovery in lymph was increased by almost threefold following liposome administration compared to non-liposomal delivery.

Membrane Stabilization and Protection

Vitamin E is incorporated into cellular membranes, where it protects the lipid bilayer from oxidative damage and maintains membrane fluidity and integrity. It also protects membrane-bound enzymes and receptors from oxidative inactivation, supporting normal cellular signaling and function. By preventing lipid peroxidation, vitamin E helps protect the integrity and function of cell membranes.

The Bioavailability Challenge

Despite its essential physiological functions, conventional oral vitamin E presents significant bioavailability challenges. Vitamin E is a highly lipophilic molecule that requires bile salt-mediated micelle formation for intestinal absorption, and its absorption is influenced by dietary fat intake and individual gastrointestinal conditions. Additionally, vitamin E is subject to extensive first-pass metabolism in the liver, which reduces the fraction of absorbed vitamin reaching systemic circulation.

These limitations have driven the development of advanced delivery systems, including liposomal encapsulation. A pharmacokinetic study in heifers demonstrated that α-tocopherol encapsulated in liposomes exhibited a lower elimination rate constant (Kd) compared with other formulations, suggesting longer plasma persistence. The study concluded that dietary supplementation with α-tocopherol encapsulated in liposomes may enhance plasma availability of this vitamin.

Liposomal DL-Alpha-Tocopherol

Liposomal encapsulation of DL-alpha-tocopherol provides a fundamentally different delivery mechanism from conventional forms. The phospholipid bilayer surrounds the vitamin E molecule, forming a protective shell that enhances stability, bioavailability, and cellular uptake. This delivery system:

• Increases α-tocopherol recovery in lymph by almost threefold following liposome administration

• Demonstrates a lower elimination rate constant (Kd), indicating longer plasma persistence compared with oil or cyclodextrin formulations

• Protects vitamin E from gastric degradation and oxidation during storage and transit

• Enables sustained release for long-lasting antioxidant protection

• Delivers vitamin E precisely to lipid-rich tissues and cell membranes

Clinical Evidence

Enhanced Plasma Persistence — Comparative Pharmacokinetic Study

A comparative pharmacokinetic study evaluated the kinetic behavior of three preparations of α-tocopherol after oral administration to eight postpubertal Friesian heifers. A single oral bolus of 5,000 U of α-tocopherol in oil, encapsulated in liposomes, or encapsulated in cyclodextrin was administered using a 4 × 4 design with 8 days between treatments. Blood samples were obtained at various times for 168 hours after treatment. Mean maximal plasma concentrations were 4.86 ± 0.49 μg/mL (oil), 5.03 ± 0.39 μg/mL (liposomal), and 5.08 ± 0.56 μg/mL (cyclodextrin), with plasma concentrations peaking 21 to 34 hours after administration. The disappearance rate constant (Kd) was less after administration of α-tocopherol encapsulated in liposomes compared with the other two preparations, suggesting that this formulation may result in longer persistence of the vitamin in plasma.

Lymphatic Absorption Enhancement

A study evaluating the incorporation of α-tocopherol in marine lipid-based liposomes demonstrated that α-tocopherol recovery in lymph was increased by almost threefold following liposome administration compared to non-liposomal delivery. This finding supports the role of liposomal encapsulation in enhancing lymphatic absorption and bypassing first-pass hepatic metabolism.

Safety and Pharmacokinetic Profile

A safety and pharmacokinetic study of liposomal antioxidant formulations containing α-tocopherol in beagle dogs revealed that the inclusion of tocopherols in the liposomal formulation significantly increased the area under the curve (AUC) and β-half life, with reductions of central compartment clearance (CL) ranging from 56% and reductions of tissue clearance (CL2) ranging from 73% to 77%. These findings demonstrate that liposomal encapsulation significantly enhances the pharmacokinetic profile of α-tocopherol, supporting its use in advanced delivery systems.

Safety and Regulatory

Vitamin E has a well-established safety profile when used appropriately. The Tolerable Upper Intake Level (UL) for supplemental vitamin E is 1,000 mg/day (approximately 1,500 IU of natural source or 1,100 IU of synthetic source) for adults. High-dose vitamin E supplementation may increase the risk of bleeding, particularly in individuals taking anticoagulant or antiplatelet medications.

Regulatory Status:

• United States — DL-α-Tocopherol is Generally Recognized as Safe (GRAS) by the FDA under 21 CFR § 184.1890 for use as a direct human food ingredient. Tocopherols are also GRAS under 21 CFR § 182.8890 as nutrients with no other limitations than current good manufacturing practice.

• European Union — DL-α-Tocopherol is authorized as a food additive (E 307c) and is permitted for use in food supplements in EU member states. The JECFA established a group ADI of 0.15–2 mg/kg body weight for dl-α-tocopherol and d-α-tocopherol concentrate, singly or in combination.

• Global Standards — Vitamin E is monographed in the USP, European Pharmacopoeia, British Pharmacopoeia, and Japanese Pharmacopoeia. DL-α-Tocopherol is listed in the FDA Substances Added to Food database with CAS Registry No. 2074-53-5.

Precautions: Vitamin E is generally well tolerated at recommended doses. High-dose vitamin E supplementation may increase the risk of bleeding, particularly in individuals taking anticoagulant or antiplatelet medications. Individuals with vitamin K deficiency or bleeding disorders should consult a healthcare professional before use. Vitamin E supplementation should be discontinued at least 2 weeks before surgery. Pregnant or lactating women and children should consult a healthcare professional before use. Vitamin E may interact with certain medications, including warfarin, aspirin, and chemotherapy agents.

Testing protocols must adhere to international standards including USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius. Formulators should verify local regulatory requirements prior to market entry.

This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.

99$/KG